文献速递血栓与止血

全髋与全膝关节置换术后90天静脉血栓栓塞风险临床预测模型的开发与验证:一项跨国研究

Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study.
PubMed 文献 · J Thromb Haemost · 2023-11-22

这项跨国队列研究利用英国数据开发了全髋/全膝关节置换术后90天静脉血栓栓塞(VTE)风险预测模型,并在丹麦数据中外部验证。英国数据集64032例手术中1.4%发生VTE,模型曲线下面积0.65(95%CI 0.63-0.67);丹麦队列36169例手术中1.0%发生VTE,曲线下面积0.64(95%CI 0.61-0.67)。结论认为该模型在开发和验证数据中表现良好,可用于估计个体术后VTE风险。

要点

  • 英国64032例全髋/全膝关节置换术后90天VTE发生率为1.4%。
  • 预测模型纳入年龄、体重指数、性别、术前1年内膀胱炎、静脉炎史、VTE史、静脉曲张、哮喘、短暂性脑缺血发作史、心肌梗死史、高血压及手术类型。
  • 丹麦36169例验证队列VTE发生率为1.0%,模型曲线下面积0.64(95%CI 0.61-0.67)。

核心结论

  • 该全髋/全膝关节置换术后90天VTE风险临床预测模型在开发数据和验证数据中表现良好,可用于估计个体术后VTE风险。

研究设计与样本

  • 跨国队列研究,开发数据来自英国牛津皇家学院全科医师研究与监测中心记录并链接医院统计与英国国家统计局常规数据,外部验证数据来自丹麦髋膝关节置换登记、国家患者登记和国家处方登记。
  • 开发采用二分类多变量逻辑回归。
  • 英国数据集纳入64032例全髋/全膝关节置换手术,丹麦验证队列纳入36169例手术。

主要发现

  • 英国数据集中64032例手术有1.4%发生VTE,模型曲线下面积为0.65(95%CI 0.63-0.67)。
  • 丹麦队列36169例手术有1.0%发生VTE,模型曲线下面积为0.64(95%CI 0.61-0.67)。
  • 验证研究中校准斜率为0.92,开发研究中校准斜率为1.00。

关键数值与推荐

  • 预测模型包含年龄、体重指数、性别、术前1年内膀胱炎、静脉炎史、VTE史、静脉曲张、哮喘、短暂性脑缺血发作史、心肌梗死史、高血压以及全髋或全膝关节置换。

临床怎么用

  • 原文结论指出该模型可用于估计个体在全髋/全膝关节置换术后发生VTE的风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of venous thromboembolism (VTE) following total hip arthroplasty (THA) and total knee arthroplasty (TKA) is 1.0% to 1.5%, despite uniform thromboprophylaxis. OBJECTIVES: To develop and validate a prediction model for 90-day VTE risk. METHODS: A multinational cohort study was performed. For model development, records were used from the Oxford Royal College of General Practitioners Research and Surveillance Centre linked to Hospital Episode Statistics and Office of National Statistics UK routine data. For external validation, data were used from the Danish Hip and Knee Arthroplasty Registry, the National Patient Registry, and the National Prescription Registry. Binary multivariable logistic regression techniques were used for development. RESULTS: In the UK data set, 64 032 THA/TKA procedures were performed and 1.4% developed VTE. The prediction model consisted of age, body mass index, sex, cystitis within 1 year before surgery, history of phlebitis, history of VTE, presence of varicose veins, presence of asthma, history of transient ischemic attack, history of myocardial infarction, presence of hypertension and THA or TKA. The area under the curve of the model was 0.65 (95% CI, 0.63-0.67). Furthermore, 36 169 procedures were performed in the Danish cohort, of whom 1.0% developed VTE. Here, the area under the curve was 0.64 (95% CI, 0.61-0.67). The calibration slope was 0.92 in the validation study and 1.00 in the development study. CONCLUSION: This clinical prediction model for 90-day VTE risk following THA and TKA performed well in both development and validation data. This model can be used to estimate an individual's risk for VTE following THA/TKA.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Nemeth B, Smeets M, Pedersen AB, et al. Development and validation of a clinical prediction model for 90-day venous thromboembolism risk following total hip and total knee arthroplasty: a multinational study. J Thromb Haemost. 2023. PMID: 38030547. doi:10.1016/j.jtha.2023.09.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。